Richard Mercado
Primary Podiatric Medicine · Miami, FLNPI 1427038538
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.5%), other and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Organogenesis Inc. at 49.2% of the total. Reporting peaked in 2021 at $4,317 and has fallen 78.4% since, to $932 in 2025. Among primary podiatric medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 186 payments — averaging $53.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$5K
- Smith+Nephew$2K
- Biotissue Holdings Inc.$2K
- Merck$250
- Paratek Pharmaceuticals, Inc.$138
- KCI USA, Inc.$113
- plus $313 from 4 others
What the payments were for
- Speaking & faculty fees$2503%
- Travel & lodging$1,87019%
- Food & beverage$5,60056%
- Other$2,20022%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 155 | $4,884 |
| Smith+Nephew | 3 | $2,341 |
| Biotissue Holdings Inc. | 13 | $1,882 |
| Merck | 1 | $250 |
| Paratek Pharmaceuticals, Inc. | 4 | $138 |
| KCI USA, Inc. | 1 | $113 |
| Boston Scientific | 1 | $109 |
| Amniox Medical, Inc. | 3 | $99 |
| Integra Lifesciences Corporation | 4 | $81 |
| Bsn Medical Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GRAFIX PL$2,200
- NEOX$1,280
- CLARIX$1,280
- PuraPly$825
- Apligraf$777
- Affinity$253
- PNEUMOVAX 23$250
- NUZYRA$125
- COLLAGENASE SANTYL$122
- Puraply Antimicrobial$116
- VAC VERAFLO$113
- PREVENA$113
- GENERAL VASCULAR INTERVENTION$109
How this compares
$9,920 in reported general payments places this provider in the 90th percentile of 68 primary podiatric medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 13 | $308 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Miami
- Eric MascellinoMiami$2K
- Allan FreedlineMiami$310
- Christopher SwartzMiami$93
- Robert SnyderTamarac$623K
- Melissa VerdeLongwood$257K
- Kevin LapoffGreenacres$64K
- Beth PearceSt Augustine$27K
- Dmitry SandlerHialeah$11K
- Gladys de LeonOrlando$8K
- Tanika HarlisPort Saint Lucie$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.